Related references
Note: Only part of the references are listed.Derivation of a Myeloid Cell-Binding Adenovirus for Gene Therapy of Inflammation
Michael O. Alberti et al.
PLOS ONE (2012)
Generation of a Kupffer Cell-evading Adenovirus for Systemic and Liver-directed Gene Transfer
Reeti Khare et al.
MOLECULAR THERAPY (2011)
Cell Entry and Trafficking of Human Adenovirus Bound to Blood Factor X Is Determined by the Fiber Serotype and Not Hexon: Heparan Sulfate Interaction
Stephanie Corjon et al.
PLOS ONE (2011)
Rapid and Efficient Clearance of Blood-borne Virus by Liver Sinusoidal Endothelium
Latha P. Ganesan et al.
PLOS PATHOGENS (2011)
Biodistribution and retargeting of FX-binding ablated adenovirus serotype 5 vectors
Raul Alba et al.
BLOOD (2010)
Efficacy of Gene Therapy for X-Linked Severe Combined Immunodeficiency
Salima Hacein-Bey-Abina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Evaluation of innate immunity and vector toxicity following inoculation of bovine, porcine or human adenoviral vectors in a mouse model
Anurag Sharma et al.
VIRUS RESEARCH (2010)
Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer
Raul Alba et al.
BLOOD (2009)
Two Key Challenges for Effective Adenovirus-Mediated Liver Gene Therapy: Innate Immune Responses and Hepatocyte-Specific Transduction
Delphyne Descamps et al.
CURRENT GENE THERAPY (2009)
Redundant and Synergistic Mechanisms Control the Sequestration of Blood-born Adenovirus in the Liver
Nelson C. Di Paolo et al.
MOLECULAR THERAPY (2009)
Vision 1 Year after Gene Therapy for Leber's Congenital Amaurosis
Artur V. Cideciyan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Adenovirus receptors and their implications in gene delivery
Anurag Sharma et al.
VIRUS RESEARCH (2009)
Adenovirus serotype 5 hexon mediates liver gene transfer
Simon N. Waddington et al.
CELL (2008)
Cell vehicle targeting strategies
J. C. Roth et al.
GENE THERAPY (2008)
Clearance of Adenovirus by Kupffer Cells Is Mediated by Scavenger Receptors, Natural Antibodies, and Complement
Zhili Xu et al.
JOURNAL OF VIROLOGY (2008)
Adenovirus-mediated in utero expression of CFTR does not improve survival of CFTR knockout mice
Lee A. Davies et al.
MOLECULAR THERAPY (2008)
Substitution of hexon hypervariable region 5 of adenovirus serotype 5 abrogates blood factor binding and limits gene transfer to liver
Frederic Vigant et al.
MOLECULAR THERAPY (2008)
Adenovirus serotype 5 hexon is critical for virus infection of heptocytes in vivo
O. Kalyuzhniy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Engineering targeted viral vectors for gene therapy
Reinhard Waehler et al.
NATURE REVIEWS GENETICS (2007)
Differential biodistribution of adenoviral vector in vivo as monitored by bioluminescence imaging and quantitative polymerase chain reaction
Mai Johnson et al.
HUMAN GENE THERAPY (2006)
Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes
Alan L. Parker et al.
BLOOD (2006)
Generation and selection of targeted adenoviruses embodying optimized vector properties
SC Noureddini et al.
VIRUS RESEARCH (2006)
In vivo analysis of a genetically modified adenoviral vector targeted to human CD40 using a novel transient transgenic model
M Izumi et al.
JOURNAL OF GENE MEDICINE (2005)
Tumor-targeted, systemic delivery of therapeutic viral vectors using hitchhiking on antigen-specific T cells
C Cole et al.
NATURE MEDICINE (2005)
Bone morphogenetic protein 4 promotes pulmonary vascular remodeling in hypoxic pulmonary hypertension
DB Frank et al.
CIRCULATION RESEARCH (2005)
Selective induction of tumor-associated antigens in murine pulmonary vasculature using double-targeted adenoviral vectors
M Everts et al.
GENE THERAPY (2005)
Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity
DM Shayakhmetov et al.
JOURNAL OF VIROLOGY (2005)
Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer
SE Raper et al.
MOLECULAR GENETICS AND METABOLISM (2003)
Combined transductional and transcriptional targeting improves the specificity of transgene expression in vivo
PN Reynolds et al.
NATURE BIOTECHNOLOGY (2001)
CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors
R Alemany et al.
GENE THERAPY (2001)
A mouse model for adenovirus gene delivery
T Tallone et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages
Y Zhang et al.
MOLECULAR THERAPY (2001)
Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver
NJ Tao et al.
MOLECULAR THERAPY (2001)
A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo
PN Reynolds et al.
MOLECULAR THERAPY (2000)
Genetic targeting of adenoviral vectors
VN Krasnykh et al.
MOLECULAR THERAPY (2000)
Share Paper
